zhongtian Bai

Dr. zhongtian Bai


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2022 in International Journal of Cancer
Verified
Journal Article
Closed access
JXJiahui Xi
Jiahui Xi
YLYonghong Li
Yonghong Li
HZHui Zhang
Hui Zhang
ZBzhongtian Bai
zhongtian Bai

22 May 2021 in Analytical Cellular Pathology
Verified
Journal Article
Open access
PDF file
BMBin Ma
Bin Ma
JLJing Li
Jing Li
WYWen-Ke Yang
Wen-Ke Yang
MZMei-Gui Zhang
Mei-Gui Zhang
XXXiaodong Xie
Xiaodong Xie
ZBzhongtian Bai
zhongtian Bai
N-trans-Feruloyloctopamine (FO), a natural compound, was reported in our previous study to inhibit a tumor cell malignant phenotype by AKT- and EMT-related signals and might be used as a promising drug for HCC treatment. However, the specific targets and detailed mechanisms still need to be clarified. Screening with RNA-Seq in Huh7 cells treated with FO revealed that 317 genes were modulated, of which 188 genes were upregulated and 129 genes were downregulated. Real-time cell analyzer and flow cytometry data reveal that tumor cell proliferation and apoptosis were impacted by FO. DAVID bioinformatic data showed that most of the biological process GO terms are related to proliferation and apoptosis. KEGG enrichment analysis showed that FO mainly regulates PI3K-AKT- and apoptosis-related signals, in which BBC3, DDIT3, NOXA, and CDKN1A on the surface serve as the novel targets of FO inducing HCC cell apoptosis. The result implied that FO might exacerbate HCC cell apoptosis by regulating BBC3, DDIT3, CDKN1A, and NOXA signals. The obstacle effect of FO can provide new targets and new credibility for the treatment of liver cancer.

30 September 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
TCTeng Cai
Teng Cai
JDJianye Dai
Jianye Dai
YLYanyan Lin
Yanyan Lin
ZBzhongtian Bai
zhongtian Bai
DLDong jing Li
Dong jing Li
WMWenbo Meng
Wenbo Meng
N-acetyltransferase 10 (NAT10) plays a crucial role in the occurrence and development of various tumors. However, the current regulatory mechanism of NAT10 in tumors is limited to its presence in tumor cells. Here, we aimed to reveal the role of NAT10 in intrahepatic cholangiocarcinoma (ICC) and investigate its effect on macrophage polarization in the tumor microenvironment (TME). The correlation between NAT10 and ICC clinicopathology was analyzed using tissue microarray (TMA), while the effect of NAT10 on ICC proliferation was verified in vitro and in vivo. Additionally, the downstream target of NAT10, C-C motif chemokine ligand 2 (CCL2), was identified by Oxford Nanopore Technologies full-length transcriptome sequencing, RNA immunoprecipitation-quantitative polymerase chain reaction, and coimmunoprecipitation experiments. It was confirmed by co-culture that ICC cells could polarize macrophages towards M2 type through the influence of NAT10 on CCL2 protein expression level. Through RNA-sequencing, molecular docking, and surface plasmon resonance (SPR) assays, it was confirmed that berberine (BBR) can specifically bind CCL2 to inhibit ICC development. High expression level of NAT10 was associated with poor clinicopathological manifestations of ICC. In vitro, the knockdown of NAT10 inhibited the proliferative activity of ICC cells and tumor growth in vivo, while its overexpression promoted ICC proliferation. Mechanically, by binding to CCL2 messenger RNA, NAT10 increased CCL2 protein expression level in ICC and their extracellular matrix, thereby promoting the proliferation of ICC cells and M2-type polarization of macrophages. BBR can target CCL2, inhibit ICC proliferation, and reduce M2-type polarization of macrophages. NAT10 promotes ICC proliferation and M2-type polarization of macrophages by up-regulating CCL2, whereas BBR inhibits ICC proliferation and M2-type polarization of macrophages by inhibiting CCL2.

24 February 2021 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
RMRuixia Ma
Ruixia Ma
MZMaomao Zhao
Maomao Zhao
XZXin Zou
Xin Zou
JZJianye Zhou
Jianye Zhou
ZBzhongtian Bai
zhongtian Bai
Hepatocellular carcinoma (HCC) is a life‑threatening cancer of the digestive system, with complex pathogenesis affected by a broad spectrum of genetic and epigenetic factors. Among several factors, microRNAs (miRNAs), which are considered regulators of the post‑transcriptional gene expression, play important roles in determining the malignant phenotype of HCC. In recent years, the advances in molecular genetics have resulted in the characterization of complex genetic factors and in the identification of epigenetic mechanisms of diseases. Accumulating data have suggested that miRNA polymorphisms are involved in tumorigenesis and prognosis, suggesting that the miRNAs may serve as a target for HCC with regard to pathogenesis and prognosis. In the present review, a comprehensive and detailed literature search was conducted and the role of miRNA polymorphisms in the pathogenesis and prognosis of HCC is summarized. The data proposed the use of miRNAs as targets for the diagnosis and treatment of HCC.

3 November 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
RMRuixia Ma
Ruixia Ma
MZMeigui Zhang
Meigui Zhang
JXJiahui Xi
Jiahui Xi
JLJing Li
Jing Li
YMYinxia Ma
Yinxia Ma
ZBzhongtian Bai
zhongtian Bai
Objectives: Protein post-translational modifications (PTMs) are closely associated with tumorigenesis, targeting PTMs of key proteins might be the focus of antitumor drug discovery. This study aimed to analyze the research progress on protein PTMs in tumorigenesis by performing qualitative and quantitative evaluations.Methods: The Web of Science Core Collection was selected as the database, and Science Citation Index Expanded was selected as the citation index. Visualization tools such as VOSviewer, CiteSpace, HistCite, and Online Analysis Platform of Bibliometrics were used to deeply explore the information of the retrieved research papers and analyze them in terms of research trends and main aspects of research.Results: The search yielded 3777 relevant articles. The results showed that the total number of PTMs related papers in cancer field has been increasing annually, with the largest number of papers published in the United States of America. The co-word cluster analysis showed that the research on PTMs and tumorigenesis was primarily focused on the following four areas, mechanism, histone, P53, key Technologies. Tumor metabolism, autophagy, and protein-protein interaction, histone ubiquitination have become new research topics.Conclusion: This study provides an important reference for the research direction and selection of topics of interest in the PTMs of cancer field.

29 June 2023 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
MZMeigui Zhang
Meigui Zhang
JLJing Li
Jing Li
RMRuixia Ma
Ruixia Ma
JXJiahui Xi
Jiahui Xi
LXLili Xi
Lili Xi
ZBzhongtian Bai
zhongtian Bai